Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)

Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE). Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Akash, Dagaonkar, Rucha S., Marshall, Dominic, Abisheganaden, John, Light, R. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192296/
https://www.ncbi.nlm.nih.gov/pubmed/28070157
http://dx.doi.org/10.1155/2016/7348239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192296/
https://www.ncbi.nlm.nih.gov/pubmed/28070157
http://dx.doi.org/10.1155/2016/7348239

Ejemplares similares